GPCR Conference: ‘Novel Applications and Cutting Edge Technologies for GPCR Screening and Profiling’
News Jul 14, 2009
Taking place at The Nucleus conference centre, Chesterford Research Park, Saffron Walden, UK from 22 - 23 September 2009, the new scientific conference ‘Novel Applications and Cutting Edge Technologies for GPCR Screening and Profiling’ will provide delegates with the opportunity to hear from thought leaders and share experiences within this field.
Keynote speaker Fiona Marshall, Chief Scientific Officer, Heptares Therapeutics, will talk about “Structure-based Drug Discovery for GPCR Targets”.
The meeting will highlight the latest technological developments and tools available for drug discovery on GPCR receptors, with key opinion leaders presenting their experience of generating high-quality screening data.
Furthermore, case studies will be described where flexible assay formats and newly available tools have enhanced throughput for successful compound screening.
This meeting is being sponsored by three pioneering companies in GPCR research, BioFocus DPI, DiscoveRx and MDS Analytical Technologies.
About 422 million people around the world, including more than 30 million Americans, have diabetes. Obesity is the most significant risk factor for type 2 diabetes. yet about 30 percent of obese people do not develop type 2 diabetes or other metabolic conditions. New research aims to understand on a cellular level, how this separation occurs.READ MORE
Measuring hand grip can help identify youths who could benefit from lifestyle changes, says new research. While other studies have shown that muscle weakness as measured by grip strength is a predictor of unhealthy outcomes - including cardiovascular and metabolic diseases - this is the first to do so for adolescent health over time.READ MORE